MedTrace Logo

Influenza Vaccine Safety and Effectiveness in Healthcare Providers

NCT01282177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1143

Last updated 2017-01-19

No results posted yet for this study

Summary

The overall objective of this study is to provide ongoing assessment of the safety and effectiveness of seasonal and pandemic H1N1 vaccines in the prevention of ILI (influenza like illness), ILI-associated work absenteeism, and laboratory-confirmed influenza in a cohort of Canadian HCP (Health care providers). Given the uncertainties around the timing of the provision of seasonal influenza immunization to HCP for the 2009/10 influenza season, this study will focus on evaluation of safety and effectiveness of pandemic influenza immunization in Year 1 and evaluation of all recommended influenza vaccines in Years 2 and 3.

Conditions

Sponsors & Collaborators

  • PHAC/CIHR Influenza Research Network

    collaborator OTHER_GOV

  • Dalhousie University

    lead OTHER

Principal Investigators

  • Shelly A McNeil, MD · Dalhousie University

  • Allison McGeer, MD · MOUNT SINAI HOSPITAL

  • Anne McCarthy, MD · The Ottawa Hospital

  • Mark Loeb, MD · Hamilton Health Sciences Center

  • Grant Stiver, MD · Vancouver General Hospital

  • Brenda Coleman, MD · MOUNT SINAI HOSPITAL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-04-30
Completion
2012-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01282177 on ClinicalTrials.gov